prospidium has been researched along with Benign Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akyshbaev, AA; Averinova, SG; Bassalyk, LS; Lichinitser, MR; Perevodchikova, NI | 1 |
Blokhin, NN | 1 |
1 trial(s) available for prospidium and Benign Neoplasms
Article | Year |
---|---|
[Clinico-pharmacological study of prospidin].
Topics: Adult; Bleomycin; Carcinoma, Small Cell; Child; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Dysgerminoma; Female; Humans; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Piperazines; Prospidium; Time Factors | 1983 |
1 other study(ies) available for prospidium and Benign Neoplasms
Article | Year |
---|---|
Drugs that make cancer retreat.
Topics: Antineoplastic Agents; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine; Piperazines; Prospidium; Tegafur | 1976 |